GB2463801B - Isoprenoid compounds, their isolation and use - Google Patents

Isoprenoid compounds, their isolation and use

Info

Publication number
GB2463801B
GB2463801B GB0917910A GB0917910A GB2463801B GB 2463801 B GB2463801 B GB 2463801B GB 0917910 A GB0917910 A GB 0917910A GB 0917910 A GB0917910 A GB 0917910A GB 2463801 B GB2463801 B GB 2463801B
Authority
GB
United Kingdom
Prior art keywords
isolation
isoprenoid compounds
isoprenoid
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB0917910A
Other versions
GB2463801A (en
GB0917910D0 (en
Inventor
Steven John Rowland
Benjamin Edward Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Plymouth University
Original Assignee
Plymouth University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Plymouth University filed Critical Plymouth University
Priority to GB0917910A priority Critical patent/GB2463801B/en
Priority claimed from GB0705299A external-priority patent/GB2447667B/en
Publication of GB0917910D0 publication Critical patent/GB0917910D0/en
Publication of GB2463801A publication Critical patent/GB2463801A/en
Application granted granted Critical
Publication of GB2463801B publication Critical patent/GB2463801B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/608—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a ring other than a six-membered aromatic ring in the acid moiety
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A61K9/1278—Post-loading, e.g. by ion or pH gradient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C13/00—Cyclic hydrocarbons containing rings other than, or in addition to, six-membered aromatic rings
    • C07C13/28—Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/02—Saturated compounds having —CHO groups bound to acyclic carbon atoms or to hydrogen
    • C07C47/105—Saturated compounds having —CHO groups bound to acyclic carbon atoms or to hydrogen containing rings
    • C07C47/11—Saturated compounds having —CHO groups bound to acyclic carbon atoms or to hydrogen containing rings monocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/02—Saturated compounds having —CHO groups bound to acyclic carbon atoms or to hydrogen
    • C07C47/12—Saturated compounds having —CHO groups bound to acyclic carbon atoms or to hydrogen containing more than one —CHO group
    • C07C47/133—Saturated compounds having —CHO groups bound to acyclic carbon atoms or to hydrogen containing more than one —CHO group containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/04—Saturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/105—Saturated compounds containing keto groups bound to acyclic carbon atoms containing rings
    • C07C49/11—Saturated compounds containing keto groups bound to acyclic carbon atoms containing rings monocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/04—Saturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/12—Ketones containing more than one keto group
    • C07C49/15—Ketones containing more than one keto group containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/26—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms containing rings other than aromatic rings
    • C07C55/28—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms containing rings other than aromatic rings monocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Dispersion Chemistry (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB0917910A 2007-03-20 2007-03-20 Isoprenoid compounds, their isolation and use Expired - Fee Related GB2463801B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0917910A GB2463801B (en) 2007-03-20 2007-03-20 Isoprenoid compounds, their isolation and use

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0917910A GB2463801B (en) 2007-03-20 2007-03-20 Isoprenoid compounds, their isolation and use
GB0705299A GB2447667B (en) 2007-03-20 2007-03-20 Isoprenoid compounds,their isolation and use

Publications (3)

Publication Number Publication Date
GB0917910D0 GB0917910D0 (en) 2009-11-25
GB2463801A GB2463801A (en) 2010-03-31
GB2463801B true GB2463801B (en) 2011-07-13

Family

ID=41785799

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0917910A Expired - Fee Related GB2463801B (en) 2007-03-20 2007-03-20 Isoprenoid compounds, their isolation and use

Country Status (1)

Country Link
GB (1) GB2463801B (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6132789A (en) * 1995-12-15 2000-10-17 National Research Council Of Canada Archaeosomes, archaeosomes containing coenzyme Q10, and other types of liposomes containing coenzyme Q10 as adjuvants and as delivery vehicles
WO2003092647A2 (en) * 2002-04-29 2003-11-13 Biotesys Gmbh Transport system in biological systems
WO2008023264A2 (en) * 2006-02-09 2008-02-28 Ocean Nutrition Canada, Ltd. Coenzyme q10 production from marine bacteria

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6132789A (en) * 1995-12-15 2000-10-17 National Research Council Of Canada Archaeosomes, archaeosomes containing coenzyme Q10, and other types of liposomes containing coenzyme Q10 as adjuvants and as delivery vehicles
WO2003092647A2 (en) * 2002-04-29 2003-11-13 Biotesys Gmbh Transport system in biological systems
WO2008023264A2 (en) * 2006-02-09 2008-02-28 Ocean Nutrition Canada, Ltd. Coenzyme q10 production from marine bacteria

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Lutnaes et al, "Structure elucidation of C80, C81 and C82 isoprenoid tetraacids responsible for naphthenate deposition in crude oil production", Organic and Biomolecular Chemistry, 2007, 5, 1873-1877 *
NISHIKAWA et al, "Design of the functionalised liposomes using the molecules having saturated isoprenoid chains derived from archaebacterial lipids", Recent Res. Devel. in Pure & Applied Chem., 1998, 2, 239-245 *
Patel et al, "Archaeobacterial ether lipid liposomes (archaeosomes) as novel vaccine and drug delivery systems", Critical reviews in Biotechnology, 1999, 19, 317-357 *
Patel et al, "Archeeosome immunostimulatory vaccine delivery system", Current Drug Delivery, 2005, 2, 407-421 *

Also Published As

Publication number Publication date
GB2463801A (en) 2010-03-31
GB0917910D0 (en) 2009-11-25

Similar Documents

Publication Publication Date Title
EP2124550A4 (en) Oxabicycloheptanes and oxabicycloheptenes, their preparation and use
GB0701426D0 (en) Compounds and their use
PL2134699T3 (en) 2-aryl-5-heterocyclyl-cyclohexane-1,3-dione compounds and their use as herbicides
TWI347842B (en) Tricyclic compounds, compositions, and methods
GB0700580D0 (en) Use
HK1151791A1 (en) Oxabicycloheptanes and oxabicycloheptenes, their preparation and use
EP2137636A4 (en) Application isolation system
GB0712503D0 (en) Use
GB0714670D0 (en) Use
EP2349990B8 (en) Aryl-phenyl-sulfonamide-phenylene compounds and their use
IL191885A0 (en) Multiple
EP2174629A4 (en) Tampon
EG25382A (en) Use of tocopherol.
GB0625001D0 (en) Short isolation
EP2170874A4 (en) Novel compounds and their use
IL183496A0 (en) Single use sinkstainer
HRP20160578T1 (en) Substituted furancarboxamides, and use thereof
GB2447667B (en) Isoprenoid compounds,their isolation and use
EP2192122A4 (en) Dithiolopyrrolone compounds, the preparation and the use thereof
GB0801319D0 (en) Compounds and their use
GB0719834D0 (en) Compounds, method and use
GB2463801B (en) Isoprenoid compounds, their isolation and use
PL381690A1 (en) Bioicidal preparation
GB0701096D0 (en) Use
GB0718559D0 (en) Compounds and their use

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20120320